Drug intelligence / Profile preview

Clicolon

Development stage: Phase 2
Lead developer: Korea Pharma
Modality: Small Molecules
Administration: Oral

Overview

**Clicolon** is an oral sodium phosphate tablet bowel-preparation product marketed by Korea Pharma for colon cleansing before colonoscopy in adults. Each Clicolon tablet contains dibasic sodium phosphate anhydrous and sodium dihydrogen phosphate monohydrate. The phosphate salts act as a saline osmotic laxative, increasing intraluminal fluid and promoting rapid evacuation of colonic contents to improve visualization during colonoscopy.

Brand names: Clicolon
Other names: sodium phosphate tablets

Beyond the preview

Go deeper on Clicolon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clicolon.

Explore the full profile